omega-Agatoxin IVA, Ca2+ channel blocker (P and Q type)
Be the first to review this product! 리뷰 제출
|
(8 제품이 사용된 논문 )
- FuncS
PubMed
Functional Studies - omega-Agatoxin IVA, Ca2+ channel blocker (P and Q type) (AB120210)
Many VGCC subtypes contribute to calcium signalling in ganglion cell bodies.
Summary of Ca2+ imaging results in RGC somata showing the following changes in paired pulse Ca2+ signal in response to drugs (applied during the second K+ pulse) compared to their control paired K+ pulses (K) : 10 μM nifedipine (29%±7%; p = 0.0003; n = 20), 100 μM verapamil (VPM; 39%±5%; p<0.0001; n = 17), 400 nM ω-agatoxin IVA (AGT; 35%±14%; p = 0.0364; n = 9), 3 μM ω-conotoxin-GVIA (CTX; 23%±10%; p = 0.0423; n = 15), 3 μM mibefradil (MIB; 21%±6%; p = 0.0011; n = 16) and 200 nM TTX (40%±9%; p = 0.0004; n = 14).
(From Figure 7C of Sargoy et al).
Sargoy et al PLoS One. 2014; 9(1): e84507. Reproduced under the Creative Commons license https://creativecommons.org/publicdomain/zero/1.0/
- Chemical Structure
Lab
Chemical Structure - omega-Agatoxin IVA, Ca2+ channel blocker (P and Q type) (AB120210)
2D chemical structure image of ab120210, omega-Agatoxin IVA, Ca2+ channel blocker (P and Q type)
특성 및 보관 정보
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
보관 정보
취급 방법
Need more advice on solubility, usage and handling? Please visit our our product support page for more details.
|
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
|
Refer to SDS for further information.
제품이 사용된 논문 (8)
Recent publications for all applications. Explore the 전체 목록 and refine your search
NPJ Parkinson's disease 9:4 PubMed36646701
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:978755 PubMed36091107
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology of the cell 27:3329-3341 PubMed27605709
2016
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 36:7184-97 PubMed27383593
2016
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 9:e84507 PubMed24416240
2014
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 33:18951-65 PubMed24285900
2013
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 7:e32256 PubMed22389692
2012
Applications
Unspecified application
Species
Unspecified reactive species
Journal of psychopharmacology (Oxford, England) 26:56-70 PubMed21890595
2011
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com